Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Inotek> ?p ?o }
Showing triples 1 to 31 of
31
with 100 triples per page.
- Inotek abstract "Inotek Pharmaceuticals is a clinical-stage drug development company developing therapies with novel mechanisms to address significant diseases of the eye.The Company's lead program, INO-8875, is being evaluated for the treatment of elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. INO-8875 has completed a Phase 1/2 clinical trial in glaucoma subjects. Treatment with INO-8875 was well tolerated and resulted in a statistically significant reduction in intraocular pressure.Additionally, Inotek has a portfolio of emerging programs targeting a broad range of retinal diseases, including age-related macular degeneration and macular edema.It is based in Lexington, Massachusetts.".
- Inotek wikiPageID "1303484".
- Inotek wikiPageLength "1021".
- Inotek wikiPageOutDegree "7".
- Inotek wikiPageRevisionID "664521346".
- Inotek wikiPageWikiLink Age-related_macular_degeneration.
- Inotek wikiPageWikiLink Category:Biotechnology_companies_of_the_United_States.
- Inotek wikiPageWikiLink Category:Companies_based_in_Middlesex_County,_Massachusetts.
- Inotek wikiPageWikiLink Category:Lexington,_Massachusetts.
- Inotek wikiPageWikiLink Glaucoma.
- Inotek wikiPageWikiLink Lexington,_Massachusetts.
- Inotek wikiPageWikiLink Macular_degeneration.
- Inotek wikiPageWikiLink Macular_edema.
- Inotek hasPhotoCollection Inotek.
- Inotek wikiPageUsesTemplate Template:Med-company-stub.
- Inotek wikiPageUsesTemplate Template:Multiple_issues.
- Inotek subject Category:Biotechnology_companies_of_the_United_States.
- Inotek subject Category:Companies_based_in_Middlesex_County,_Massachusetts.
- Inotek subject Category:Lexington,_Massachusetts.
- Inotek hypernym Company.
- Inotek type Article.
- Inotek type Company.
- Inotek type Article.
- Inotek type Company.
- Inotek comment "Inotek Pharmaceuticals is a clinical-stage drug development company developing therapies with novel mechanisms to address significant diseases of the eye.The Company's lead program, INO-8875, is being evaluated for the treatment of elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. INO-8875 has completed a Phase 1/2 clinical trial in glaucoma subjects.".
- Inotek label "Inotek".
- Inotek sameAs m.04rbgz.
- Inotek sameAs Q6036654.
- Inotek sameAs Q6036654.
- Inotek wasDerivedFrom Inotek?oldid=664521346.
- Inotek isPrimaryTopicOf Inotek.